Assessing the efficacy of combined treatment using bedaquiline against clinical isolates of multidrug-resistant Mycobacterium tuberculosis in vitro and the macrophage model
Abstract
PURPOSE: Combination treatments can shorten treatment time and reduce drug side effects. The aim of this study was to assess the efficacy of combined treatment using bedaquiline (BDQ) against clinical isolates of multidrug-resistant (MDR) Mycobacterium tuberculosis (M. tuberculosis). METHODS: This cross-sectional study was performed on 15 drug-resistant isolates of M. tuberculosis. After determining the Minimum inhibitory concentration (MIC) of antibiotics, the fractional inhibitor concentration index (FICI) was evaluated using a checkerboard resazurin microtitration assay (REMA) to evaluate their interaction profiles against the M. tuberculosis isolates. The macrophage model was used to study the activity of synergistic compounds and the expression level of macrophage genes were evaluated by real-time PCR. RESULTS: All isolates had MIC ≥ 0.25 µg/mL for BDQ. Of the 15 isolates, only 2 observed a synergistic effect between BDQ and other antibiotics. The expression of macrophage genes (FABP5, HERG, RPL24, and SCARB1) infected with these two isolates, was significantly increased by the combination of BDQ+ gemifloxacin (GEM), BDQ + Rifampicin (RIF), BDQ + moxifloxacin (MFX), and BDQ + isoniazid (INH) (p < 0.01). CONCLUSION: Despite resistance to BDQ, the combination treatments showed a positive effect in the macrophage cell line model. Therefore, it can be concluded that the combination treatment with BDQ may enhanced the innate immune response of macrophages against M.…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.